Company Profile

Vertex Pharmaceuticals

Canonical company identity and public leadership record.

USNASDAQ: VRTX

SPX NDX

Follow Official website

Public sources: 2 reviewed
Published leadership records: 21
Last reviewed: Sep 13, 2026

View sources

Company overview

Business, legal identity, ownership structure and classifications.

Sector and industry values retain their source labels. A classification provider, taxonomy version and assignment date are not established unless the cited record states them.

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

S&P 500S&P Dow Jones Indices · NASDAQ: VRTXcurrentEvidence

Effective: Sep 23, 2013
Removal: Not stated
Announced: Not stated
Last verified: Sep 2, 2026
Verification: inferred
Source: Slickcharts S&P 500 constituent table (public observation, not S&P DJI license)

Nasdaq-100Nasdaq · NASDAQ: VRTXcurrentEvidence

Effective: Sep 1, 2026
Removal: Not stated
Announced: Not stated
Last verified: Sep 2, 2026
Verification: exchange verified
Source: Nasdaq official Nasdaq-100 list-type API

As of Sep 13, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Governance

Board leadership, management, committees and their disclosed responsibilities.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

10 public records

Amit K. Sachdev, J.D.

Executive Vice President, Chief Patient and External Affairs Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Charles F. Wagner, Jr.

Executive Vice President, Chief Operating and Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Craig B. Thompson, M.D.

Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Duncan J. McKechnie

Executive Vice President, Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

E. Morrow Morrey Atkinson, III, Ph.D.

Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Jonathan Biller, J.D.

Executive Vice President, Chief Legal Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Kristen C. Ambrose, CPA

Senior Vice President, Chief Accounting Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Mark Bunnage, D.Phil

Executive Vice President, Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Ourania Nia Tatsis, Ph.D.

Executive Vice President, Chief Regulatory and Quality Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Reshma Kewalramani, M.D.

Chief Executive Officer and President

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: VRTX executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

11 public records

Jeffrey M. Leiden

Chair

Board chairIndependence not stated

State: confirmed
Effective: From Jan 1, 2009
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2009

Alan Garber

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2017
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2017

Bruce Sachs

Lead Independent Director

Independence not stated

State: confirmed
Effective: From Jan 1, 1998
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceApr 2, 2026

Diana McKenzie

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2020
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2020

Jennifer Schneider

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2024
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2024

Lloyd Carney

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2019
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2019

Michel Lagarde

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2023
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2023

Nancy Thornberry

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2023
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2023

Reshma Kewalramani

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2020
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceApr 2, 2026

Sangeeta Bhatia

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2015
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2015

Suketu Upadhyay

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2022
Confidence: 95%
Evidence: Vertex Pharmaceuticals Incorporated director board sourceJan 1, 2022

Disclosure boundary

Governance and independence

Only current, confirmed leadership roles with public evidence are included in the canonical projection.

Record	Status	Authority	Effective

Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.

Investors & capital

Ownership, funding and dated financial information.

Ownership disclosures retain their reporting dates and source types. Economic ownership, investment discretion and voting authority are distinct. Activism and settlement-dated short interest are not established by holdings or short-sale volume.

Risk & assurance

Disclosed coverage, ratings and assurance scope.

Credit-rating evidence, where published, appears in the Governance and Basis sections with its source and reporting date. Insurance coverage, cyber ratings and assurance reports require their own issuer, scope, date and usage rights. Indemnification does not establish insurance coverage.

Legal & regulatory

Proceedings and outcomes with exact entity and source scope.

Structured legal matters are unavailable in this projection. A matter requires the exact entity, court or regulator, docket or source, dates and procedural status. Allegations and findings remain distinct.

Ecosystem

Published relationships and related records.

Connections

Explore the roles, education and affiliations published in this record.

Select a connection

Alan Garber

Open Alan Garber profile →

Alan Garber: Director

2017-01-01 → End not stated

Date not established · source reported

Observed: 2026-09-13

Vertex Pharmaceuticals Incorporated director board source

Dashed lines mark past roles. Select a connection to see its dates and sources.

Basis

Identifiers, sources and record limitations.

Identifiers

Alpha ID: alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9
Canonical record: https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-ma
Record version: public-1

Evidence & record status

Observed: Sep 13, 2026
Reviewed: Sep 13, 2026
Verification: source reported

Dates belong to the cited record. Publication does not establish that every disclosure is current.

Explore evidence ledger

Source documents

Alpha canonical company public projectionAlpha canonical company public projection · Date unavailable
VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13) · Date unavailable
Vertex Pharmaceuticals Incorporated director board sourcesec_filing · Apr 3, 2025
Vertex Pharmaceuticals Incorporated director board sourcesec_filing · Apr 3, 2025

All 12 sources

Cite this record

Vertex Pharmaceuticals

alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9

Company record

At a glance

Legal name: VERTEX PHARMACEUTICALS INC / MA
Sector: Healthcare
Primary listing: NASDAQ: VRTX
Headquarters: US

Profile controls

Represent this company?

An authorized company representative can request access to suggest updates. Alpha confirms authority before granting profile control or publishing a change.

Request profile access

Suggest a correction Submit supporting evidence

Alpha Eval: Not published. This identity record is not an Alpha rating, score, or investment opinion.

Related records

Associated public records

Connected records

Roles and affiliations in this public record.

Alan Garber
Director
Amit K. Sachdev, J.D.
Executive Vice President, Chief Patient and External Affairs Officer
Bruce Sachs
Lead Independent Director

Explore connections →

Vertex Pharmaceuticals

Company overview

About

Identity and status

Public listing published

Index memberships

Governance

Executive leadership

Executive team

Boards & Committees

Board roles

Governance and independence

Investors & capital

Risk & assurance

Legal & regulatory

Ecosystem

Connections

Alan Garber

Alan Garber: Director

Featured coverage

Basis

Identifiers

Sources and published information

Alpha canonical company public projection

VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)